ArticleDermatologic therapy2022

Adverse outcome and severity of COVID-19 in patients with autoimmune bullous diseases: A historical cohort study.

Fateme Shirzad Moghadam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.